0.01% Lacripep ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
53	シェーグレン症候群	1

53. シェーグレン症候群

---

臨床試験数 : 305 /  薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03226444 (ClinicalTrials.gov)	June 30, 2017	19/7/2017	Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome	A Double-Masked, Randomized, Multi-Center Phase 2 Study to Evaluate the Efficacy and Safety of Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome	Primary Sjögren Syndrome;Dry Eye	Drug: 0.005% Lacripep;Drug: 0.01% Lacripep;Drug: Placebo	TearSolutions, Inc.	NULL	Completed	18 Years	N/A	All	204	Phase 1/Phase 2	United States